INTERNATIONAL PATENT: RETINALGENIX TECHNOLOGIES INC. FILES APPLICATION FOR "SUSTAINED RELEASE OF FENOFIBRATE TO TREAT AGE-RELATED MACULAR DEGENERATION OR DIABETIC RETINOPATHY"

GENEVA, April 8 -- RETINALGENIX TECHNOLOGIES INC. (1450 N. McDowell Blvd.Petaluma, California 94954) filed a patent application (PCT/US2024/048541) for "SUSTAINED RELEASE OF FENOFIBRATE TO TREAT AGE-RELATED MACULAR DEGENERATION OR DIABETIC RETINOPATHY" on Sep 26, 2024. With publication no. WO/2025/072429, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHASALOW, Fred (c/o RetinalGenix Technologies Inc.1450 N. McDowell Blvd.Petaluma, California 94954), KATZMAN, Jerry (c/o RetinalGenix Technologies Inc.1450 N. McDowell Blvd...